Overall, the interleukin profiles indicate that IL-8 and IL-33 are more closely associated with localized or intermediate stages of tumor invasion, while IL-17A demonstrates a steep decline in advanced disease, potentially reflecting immune suppression during metastatic progression. The gene discussed is IL33; the disease is neoplasm.